EN1: Potential Drug Target for Cancer and Other Diseases (G2019)

Target Name: EN1

NCBI ID: G2019

Content of Review Report on EN1 Target / Biomarker

EN1

EN1: Potential Drug Target for Cancer and Other Diseases

EN1, or engrailed homolog 1, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer.

One of the key functions of EN1 is its role in cell proliferation. EN1 has been shown to promote the growth and survival of cancer cells, and to inhibit the death of cancer cells. This suggests that EN1 may be a potential drug target for cancer treatment.

In addition to its role in cell proliferation, EN1 is also involved in a number of other cellular processes that are important for normal development and function. For example, EN1 has been shown to play a role in the development and maintenance of tissues, such as the skin and hair. It is also involved in the regulation of cell signaling pathways, which are important for the proper functioning of cells.

EN1 has also been implicated in a number of other diseases and disorders. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's. It is also involved in the regulation of the immune system, which is important for the prevention of infections and diseases.

Despite the potential implications of EN1 as a drug target or biomarker, much more research is needed to fully understand its role in the body and its potential therapeutic uses. Currently, there are no approved drugs that are specifically targeting EN1. Researchers are actively working to develop new treatments that can specifically target EN1, and these efforts are likely to continue to be successful as the understanding of EN1's role in the body and its potential therapeutic uses continues to grow.

In conclusion, EN1 is a protein that has been shown to play a number of important roles in various cellular processes throughout the body. Its involvement in cell proliferation and the regulation of cellular signaling pathways makes it a potential drug target for a number of diseases. Further research is needed to fully understand its role in the body and its potential therapeutic uses.

Protein Name: Engrailed Homeobox 1

Functions: Required for proper formation of the apical ectodermal ridge and correct dorsal-ventral patterning in the limb

The "EN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets